|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowance for doubtful accounts of $25 at March 31, 2022 and December 31, 2021. | ||||||||||||||||||||
| Inventory, net | ||||||||||||||||||||
| Stock subscription receivable | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Intangible assets, net of accumulated amortization | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Accrued expense | ||||||||||||||||||||
| Accrued interest payable to related parties | ||||||||||||||||||||
| Convertible lines of credit to related parties, net of discount | ||||||||||||||||||||
| Notes payable to related parties | ||||||||||||||||||||
| Operating lease liabilities, current portion | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Note payable, current portion | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Other long-term liabilities: | ||||||||||||||||||||
| Note payable - bank, net of currentportion | ||||||||||||||||||||
| Note payable, net of current portion | ||||||||||||||||||||
| Operating lease liabilities, net of current portion | ||||||||||||||||||||
| Pension obligation | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Convertible Redeemable Preferred Stock, $0.01 par value | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Series D Preferred Stock | ||||||||||||||||||||
| Series D Convertible Redeemable Preferred Stock, $0.01 par value, designated 26,000 shares, 23,111 and 22,863 shares issued at March 31, 2021 and December 31, 2020, respectively and 22,757 and 22,863 shares outstanding at March 31, 2021 and December 31 2020, respectively; liquidation preference $22,757 and $22,863 at March 31, 2021 and December 31, 2020, respectively. | ||||||||||||||||||||
| Series D Convertible Redeemable Preferred Stock, $0.01 par value, designated 26,000 shares, 23,362and 22,863 shares issued at June 30, 2021 (unaudited) and December 31, 2020, respectively and 22,958 and 22,863 shares outstanding at June 30, 2021 (unaudited) and December 31, 2020, respectively; liquidation preference $22,958 and $22,863 at June 30, 2021 (unaudited) and December 31, 2020, respectively. | ||||||||||||||||||||
| Series D Convertible Redeemable Preferred Stock, $0.01 par value, 26,000 shares designated; 24,115 and 23,862 issued at March 31, 2022 (unaudited) and December 31, 2021, respectively, and 23,469 and 23,216 shares outstanding at March 31, 2022 (unaudited) and December 31, 2021, respectively; liquidation preference of $23,469 and $23,216 at March 31, 2022 (unaudited) and December 31, 2021, respectively. | ||||||||||||||||||||
| Shareholders’ Deficit: | ||||||||||||||||||||
| Series B Convertible Redeemable Preferred Stock, $0.01 par value, 750,000 shares designated; 389,400 shares issued and 239,400 shares outstanding at March 31, 2022 (unaudited) and December 31, 2021; liquidation preference $620 and $607 at March 31, 2022 (unaudited) and December 31, 2021, respectively. | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series A-1 Preferred Stock | ||||||||||||||||||||
| Series A-1 Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series D Preferred Stock | ||||||||||||||||||||
| Common Stock, $0.01 par value, 2,000,000,000 shares authorized; 347,281,946 and 347,240,045 shares issued at March 31, 2022 (unaudited) and December 31, 2021, respectively, and 347,275,242 and 347,233,341 shares outstanding at March 31, 2022 (unaudited) and December 31, 2021, respectively. | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost 6,704 shares | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Shareholders’ Deficit | ||||||||||||||||||||
| Total Liabilities, Mezzanine Equity and Shareholders’ Deficit | ||||||||||||||||||||
Loading...
